J. L. Bainbridge & Co. Inc. Acquires Shares of 27,150 Agilent Technologies, Inc. $A

J. L. Bainbridge & Co. Inc. bought a new stake in shares of Agilent Technologies, Inc. (NYSE:A) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 27,150 shares of the medical research company’s stock, valued at approximately $3,606,000. Agilent Technologies makes up 0.3% of J. L. Bainbridge & Co. Inc.’s holdings, making the stock its 27th largest position.

A number of other hedge funds and other institutional investors have also recently modified their holdings of A. State Street Corp lifted its position in Agilent Technologies by 1.9% during the 4th quarter. State Street Corp now owns 12,681,792 shares of the medical research company’s stock valued at $1,725,611,000 after acquiring an additional 241,029 shares during the period. Geode Capital Management LLC grew its holdings in Agilent Technologies by 0.3% in the fourth quarter. Geode Capital Management LLC now owns 7,425,861 shares of the medical research company’s stock worth $1,006,519,000 after purchasing an additional 25,139 shares during the period. Morgan Stanley grew its holdings in Agilent Technologies by 15.9% in the fourth quarter. Morgan Stanley now owns 5,041,881 shares of the medical research company’s stock worth $686,049,000 after purchasing an additional 692,202 shares during the period. Norges Bank bought a new position in shares of Agilent Technologies during the fourth quarter valued at approximately $549,158,000. Finally, Cantillon Capital Management LLC lifted its holdings in shares of Agilent Technologies by 0.8% during the fourth quarter. Cantillon Capital Management LLC now owns 3,115,638 shares of the medical research company’s stock valued at $423,945,000 after purchasing an additional 23,493 shares during the last quarter.

Analysts Set New Price Targets

A has been the topic of a number of analyst reports. Barclays boosted their price target on Agilent Technologies from $145.00 to $150.00 and gave the stock an “overweight” rating in a research report on Wednesday, June 24th. TD Cowen boosted their target price on Agilent Technologies from $147.00 to $155.00 and gave the stock a “buy” rating in a report on Thursday, May 28th. Morgan Stanley increased their target price on Agilent Technologies from $160.00 to $175.00 and gave the stock an “overweight” rating in a research note on Wednesday. Sanford C. Bernstein started coverage on Agilent Technologies in a report on Friday, June 26th. They set an “outperform” rating and a $155.00 price target for the company. Finally, Weiss Ratings raised Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research report on Tuesday, June 2nd. Two investment analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat.com, Agilent Technologies presently has a consensus rating of “Moderate Buy” and a consensus target price of $160.24.

Agilent Technologies Price Performance

Shares of A opened at $149.33 on Friday. Agilent Technologies, Inc. has a twelve month low of $108.35 and a twelve month high of $160.27. The company has a market capitalization of $42.18 billion, a P/E ratio of 29.99, a price-to-earnings-growth ratio of 2.62 and a beta of 1.25. The firm has a 50 day moving average of $135.12 and a 200 day moving average of $125.40. The company has a quick ratio of 1.62, a current ratio of 2.10 and a debt-to-equity ratio of 0.43.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Wednesday, May 27th. The medical research company reported $1.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.41 by $0.08. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The business had revenue of $1.83 billion for the quarter, compared to analysts’ expectations of $1.80 billion. During the same period in the prior year, the firm posted $1.31 EPS. The firm’s quarterly revenue was up 10.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. As a group, equities research analysts anticipate that Agilent Technologies, Inc. will post 6.03 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, July 22nd. Stockholders of record on Tuesday, June 30th were paid a $0.255 dividend. The ex-dividend date was Tuesday, June 30th. This represents a $1.02 annualized dividend and a dividend yield of 0.7%. Agilent Technologies’s payout ratio is currently 20.48%.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.